These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 31985)
1. Prospects for the prevention of bacterial meningitis with polysaccharide vaccines. Gotschlich EC; Austrian R; Cvjetanović B; Robbins JB Bull World Health Organ; 1978; 56(4):509-18. PubMed ID: 31985 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. Peltola H; Mäkelä H; Käyhty H; Jousimies H; Herva E; Hällström K; Sivonen A; Renkonen OV; Pettay O; Karanko V; Ahvonen P; Sarna S N Engl J Med; 1977 Sep; 297(13):686-91. PubMed ID: 408682 [TBL] [Abstract][Full Text] [Related]
3. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524 [TBL] [Abstract][Full Text] [Related]
5. Conjugate vaccines--a breakthrough in vaccine development. Mäkelä PH Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Campagne G; Schuchat A; Djibo S; Ousséini A; Cissé L; Chippaux JP Bull World Health Organ; 1999; 77(6):499-508. PubMed ID: 10427935 [TBL] [Abstract][Full Text] [Related]
7. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846 [TBL] [Abstract][Full Text] [Related]
8. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Peltola H; Käyhty H; Sivonen A; Mäkelä H Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348 [TBL] [Abstract][Full Text] [Related]
10. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis. Lieberman JM; Greenberg DP; Ward JI Infect Dis Clin North Am; 1990 Dec; 4(4):703-29. PubMed ID: 2126022 [TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Dashefsky B; Wald E; Guerra N; Byers C Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519 [TBL] [Abstract][Full Text] [Related]
12. Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. Barrett DJ Adv Pediatr; 1985; 32():139-58. PubMed ID: 3909772 [TBL] [Abstract][Full Text] [Related]
13. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. Campbell H; Byass P; Ahonkhai VI; Vella PP; Greenwood BM Pediatrics; 1990 Jul; 86(1):102-7. PubMed ID: 2113671 [TBL] [Abstract][Full Text] [Related]
14. Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization. Overturf GD; Selzer JW; Chan L; Weiss J; Field R; Rigau-Perez JG; Powars D; Uy C; Pang EJ; Honig G; Steele R; Edmonds R; Portnoy B Am J Pediatr Hematol Oncol; 1982; 4(1):25-35. PubMed ID: 7091574 [TBL] [Abstract][Full Text] [Related]
16. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate). Gray BM Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology and outcome of bacterial meningitis in Canadian children: 1998-1999. Husain E; Chawla R; Dobson S; Dele Davies H; Clin Invest Med; 2006 Jun; 29(3):131-5. PubMed ID: 17058430 [TBL] [Abstract][Full Text] [Related]
18. [Immunological principles of polysaccharide-protein conjugate vaccination]. Meyer M; Gahr M Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396 [TBL] [Abstract][Full Text] [Related]
19. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736 [TBL] [Abstract][Full Text] [Related]